Intuitive Surgical Inc (NASDAQ:ISRG) reported its fourth-quarter results in line with its preannouncement and announced a “measured” guidance for 2026, according to BTIG.

The Intuitive Surgical Analyst: Analyst Ryan Zimmerman reiterated a Buy rating and price target of $616.

The Intuitive Surgical Thesis: The company’s revenues grew 18.8% year-on-year to $2.866 billion and adjusted earnings came in at $2.53 per share, higher than the initial consensus estimates of $2.723 billion and $2.26 per share, Zimmerman said in the note.

  • Check …

Full story available on Benzinga.com